NA High Content Screening Market - Industry Trends and Forecast to 2030

Description

List of Tables

The North America high content screening market is expected to reach USD 1,918,847.03 thousand by 2030 from USD 1,083,968.48 thousand in 2022, growing at a CAGR of 7.4% during the forecast period of 2023 to 2030.

Market Segmentation

North America High Content Screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030.

Overview of North America High Content Screening Market Dynamics

Driver
Increasing drug discovery and development activities
Restrain
High cost associated with initial setup and maintenance
Opportunity
The growing number of Contract Research Organizations (CROs) providing HCS services

Market Players

Some of the major market players operating in the North America high content screening market are:

BD
Merck KGaA
Corning Incorporated
Carl Zeiss AG
Sartorius AG
EVIDENT
Zifo RnD Solutions
Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Yokogawa Electric Corporation
Sysmex Corporation
Genedata AG
De Novo Software
Araceli Biosciences
Miltenyi Biotec
Aligned Genetics, Inc.

1 INTRODUCTION 19

1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 OVERVIEW OF THE NORTH AMERICA HIGH CONTENT SCREENING MARKET 19
1.4 LIMITATIONS 21
1.5 MARKETS COVERED 21

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 PRODUCT TYPE LIFELINE CURVE 31
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 33
2.10 MARKET APPLICATION COVERAGE GRID 34
2.11 VENDOR SHARE ANALYSIS 35
2.12 SECONDARY SOURCES 36
2.13 ASSUMPTIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 39

4.1 PESTEL ANALYSIS 40
4.2 PORTER'S FIVE FORCES MODEL 41

5 NORTH AMERICA HIGH CONTENT SCREENING MARKET: REGULATIONS 42

6 MARKET OVERVIEW, NORTH AMERICA HIGH CONTENT SCREENING MARKET 44

6.1 DRIVERS 46
- 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 46
- 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 46
- 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 47
- 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 48
6.2 RESTRAINTS 48
- 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 48
- 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 49
6.3 OPPORTUNITIES 50
- 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 50
- 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 50
- 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 51
6.4 CHALLENGES 51
- 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 51
- 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 52

7 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 53

7.1 OVERVIEW 54
7.2 INSTRUMENTS 57
- 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 58
  - 7.2.1.1 FIXED 58
  - 7.2.1.2 MOBILE 58
- 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 58
  - 7.2.2.1 FIXED 59
  - 7.2.2.2 MOBILE 59
- 7.2.3 FLOW CYTOMETRY 59
- 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 59
- 7.2.5 MICROPLATE MOVER 59
- 7.2.6 OTHERS 59
7.3 SOFTWARE 59
7.4 CONSUMABLES 60
- 7.4.1 REAGENTS & ASSAY KITS 61
- 7.4.2 MICROPLATES 61
- 7.4.3 OTHERS 61
7.5 ACCESSORIES 61
7.6 SERVICES 62

8 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY APPLICATION 64

8.1 OVERVIEW 65
8.2 PRIMARY AND SECONDARY SCREENING 68
- 8.2.1 INSTRUMENTS 69
- 8.2.2 CONSUMABLES 69
- 8.2.3 ACCESSORIES 69
- 8.2.4 SERVICES 69
8.3 TARGET IDENTIFICATION AND VALIDATION 69
- 8.3.1 INSTRUMENTS 70
- 8.3.2 CONSUMABLES 70
- 8.3.3 ACCESSORIES 70
- 8.3.4 SERVICES 71
8.4 TOXICITY STUDIES 71
- 8.4.1 INSTRUMENTS 72
- 8.4.2 CONSUMABLES 72
- 8.4.3 ACCESSORIES 72
- 8.4.4 SERVICES 72
8.5 COMPOUND PROFILING 72
- 8.5.1 INSTRUMENTS 73
- 8.5.2 CONSUMABLES 73
- 8.5.3 ACCESSORIES 73
- 8.5.4 SERVICES 74
8.6 OTHER APPLICATIONS 74

9 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 75

9.1 OVERVIEW 76
9.2 MICROSCOPY 79
9.3 FLOW CYTOMETRY 79
9.4 IMMUNOHISTOCHEMISTRY 80
9.5 MASS SPECTROMETRY 81
9.6 ELISA 82
9.7 WESTERN BLOTTING 83
9.8 OTHERS 83
- 9.8.1 3D CELL CULTURE MODEL 84
  - 9.8.1.1 STEROIDS 85
  - 9.8.1.2 ORGANOIDS 85
  - 9.8.1.3 TISSUE ON A CHIP 85
- 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 85
- 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 85

10 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY END USER 86

10.1 OVERVIEW 87
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 90
- 10.2.1 INSTRUMENTS 90
- 10.2.2 CONSUMABLES 91
- 10.2.3 ACCESSORIES 91
- 10.2.4 SERVICES 91
10.3 CONTRACT RESEARCH ORGANIZATIONS 91
- 10.3.1 INSTRUMENTS 92
- 10.3.2 CONSUMABLES 92
- 10.3.3 ACCESSORIES 92
- 10.3.4 SERVICES 92
10.4 LABORATORIES 93
- 10.4.1 INSTRUMENTS 94
- 10.4.2 CONSUMABLES 94
- 10.4.3 ACCESSORIES 94
- 10.4.4 SERVICES 94
10.5 ACADEMIC AND GOVERNMENT INSTITUTES 94
- 10.5.1 INSTRUMENTS 95
- 10.5.2 CONSUMABLES 95
- 10.5.3 ACCESSORIES 95
- 10.5.4 SERVICES 95
10.6 OTHERS 96

11 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 97

11.1 OVERVIEW 98
11.2 DIRECT TENDERS 101
11.3 RETAIL SALES 101

12 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY REGION 103

12.1 NORTH AMERICA 104
- 12.1.1 U.S. 115
- 12.1.2 CANADA 122
- 12.1.3 MEXICO 129

13 NORTH AMERICA HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 136

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 136

14 NORTH AMERICA CONTENT SCREENING MARKET, COMPANY PROFILES 137

14.1 THERMO FISHER SCIENTIFIC INC. (2022) 137
- 14.1.1 COMPANY SNAPSHOT 137
- 14.1.2 REVENUE ANALYSIS 137
- 14.1.3 COMPANY SHARE ANALYSIS 138
- 14.1.4 PRODUCT PORTFOLIO 138
- 14.1.5 RECENT DEVELOPMENT 138
14.2 BD 139
- 14.2.1 COMPANY SNAPSHOT 139
- 14.2.2 REVENUE ANALYSIS 139
- 14.2.3 COMPANY SHARE ANALYSIS 140
- 14.2.4 PRODUCT PORTFOLIO 140
- 14.2.5 RECENT DEVELOPMENTS 140
14.3 PERKINELMER INC. (2022) 141
- 14.3.1 COMPANY SNAPSHOT 141
- 14.3.2 REVENUE ANALYSIS 141
- 14.3.3 COMPANY SHARE ANALYSIS 142
- 14.3.4 PRODUCT PORTFOLIO 142
- 14.3.5 RECENT DEVELOPMENTS 143
14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 144
- 14.4.1 COMPANY SNAPSHOT 144
- 14.4.2 REVENUE ANALYSIS 144
- 14.4.3 COMPANY SHARE ANALYSIS 145
- 14.4.4 PRODUCT PORTFOLIO 145
- 14.4.5 RECENT DEVELOPMENT 145
14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 146
- 14.5.1 COMPANY SNAPSHOT 146
- 14.5.2 REVENUE ANALYSIS 146
- 14.5.3 COMPANY SHARE ANALYSIS 147
- 14.5.4 PRODUCT PORTFOLIO 147
- 14.5.5 RECENT DEVELOPMENT 148
14.6 AGILENT TECHNOLOGIES, INC. (2022) 149
- 14.6.1 COMPANY SNAPSHOT 149
- 14.6.2 REVENUE ANALYSIS 149
- 14.6.3 PRODUCT PORTFOLIO 150
- 14.6.4 RECENT DEVELOPMENT 150
14.7 ALIGNED GENETICS, INC. (2022) 151
- 14.7.1 COMPANY SNAPSHOT 151
- 14.7.2 REVENUE ANALYSIS 151
- 14.7.3 PRODUCT PORTFOLIO 152
- 14.7.4 RECENT DEVELOPMENT 152
14.8 ARACELI BIOSCIENCES 153
- 14.8.1 COMPANY SNAPSHOT 153
- 14.8.2 PRODUCT PORTFOLIO 153
- 14.8.3 RECENT DEVELOPMENT 153
14.9 AXXAM S.P.A 154
- 14.9.1 COMPANY SNAPSHOT 154
- 14.9.2 PRODUCT PORTFOLIO 154
- 14.9.3 RECENT DEVELOPMENT 154
14.10 BIO-RAD LABORATORIES, INC. (2022) 155
- 14.10.1 COMPANY SNAPSHOT 155
- 14.10.2 REVENUE ANALYSIS 155
- 14.10.3 PRODUCT PORTFOLIO 156
- 14.10.4 RECENT DEVELOPMENTS 156
14.11 CARL ZEISS AG 157
- 14.11.1 COMPANY SNAPSHOT 157
- 14.11.2 REVENUE ANALYSIS 157
- 14.11.3 PRODUCT PORTFOLIO 158
- 14.11.4 RECENT DEVELOPMENT 158
14.12 CORNING INCORPORATED 159
- 14.12.1 COMPANY SNAPSHOT 159
- 14.12.2 REVENUE ANALYSIS 159
- 14.12.3 PRODUCT PORTFOLIO 160
- 14.12.4 RECENT DEVELOPMENT 160
14.13 DE NOVO SOFTWARE 161
- 14.13.1 COMPANY SNAPSHOT 161
- 14.13.2 PRODUCT PORTFOLIO 161
- 14.13.3 RECENT DEVELOPMENTS 161
14.14 EVIDENT 162
- 14.14.1 COMPANY SNAPSHOT 162
- 14.14.2 PRODUCT PORTFOLIO 162
- 14.14.3 RECENT DEVELOPMENT 162
14.15 GENEDATA AG 163
- 14.15.1 COMPANY SNAPSHOT 163
- 14.15.2 PRODUCT PORTFOLIO 163
- 14.15.3 RECENT DEVELOPMENT 163
14.16 MERCK KGAA 164
- 14.16.1 COMPANY SNAPSHOT 164
- 14.16.2 REVENUE ANALYSIS 164
- 14.16.3 PRODUCT PORTFOLIO 165
- 14.16.4 RECENT DEVELOPMENTS 165
14.17 MILTENYI BIOTEC 166
- 14.17.1 COMPANY SNAPSHOT 166
- 14.17.2 PRODUCT PORTFOLIO 166
- 14.17.3 RECENT DEVELOPMENT 167
14.18 SARTORIUS AG 168
- 14.18.1 COMPANY SNAPSHOT 168
- 14.18.2 REVENUE ANALYSIS 168
- 14.18.3 PRODUCT PORTFOLIO 169
- 14.18.4 RECENT DEVELOPMENTS 169
14.19 SYSMEX CORPORATION 170
- 14.19.1 COMPANY SNAPSHOT 170
- 14.19.2 REVENUE ANALYSIS 170
- 14.19.3 PRODUCT PORTFOLIO 171
- 14.19.4 RECENT DEVELOPMENT 171
14.20 ZIFO RND SOLUTIONS 172
- 14.20.1 COMPANY SNAPSHOT 172
- 14.20.2 PRODUCT PORTFOLIO 172
- 14.20.3 RECENT DEVELOPMENTS 172

15 QUESTIONNAIRE 173

16 RELATED REPORTS 177

LIST OF TABLES

TABLE 1 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 55
TABLE 2 NORTH AMERICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 56
TABLE 3 NORTH AMERICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 57
TABLE 4 NORTH AMERICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 57
TABLE 5 NORTH AMERICA HIGH-CONTENT AND SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 58
TABLE 6 NORTH AMERICA SOFTWARES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 59
TABLE 7 NORTH AMERICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 60
TABLE 8 NORTH AMERICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 60
TABLE 9 NORTH AMERICA ACCESSORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 61
TABLE 10 NORTH AMERICA SERVICES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 62
TABLE 11 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 66
TABLE 12 NORTH AMERICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 13 NORTH AMERICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 68
TABLE 14 NORTH AMERICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 15 NORTH AMERICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 69
TABLE 16 NORTH AMERICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 17 NORTH AMERICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 71
TABLE 18 NORTH AMERICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
TABLE 19 NORTH AMERICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 72
TABLE 20 NORTH AMERICA OTHER APPLICATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 21 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 77
TABLE 22 NORTH AMERICA MICROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 23 NORTH AMERICA FLOW CYTOMETRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 24 NORTH AMERICA IMMUNOHISTOCHEMISTRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 25 NORTH AMERICA MASS SPECTROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 26 NORTH AMERICA ELISA IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 27 NORTH AMERICA WESTERN BLOTTING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
TABLE 28 NORTH AMERICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 83
TABLE 29 NORTH AMERICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 83
TABLE 30 NORTH AMERICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 84
TABLE 31 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 88
TABLE 32 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
TABLE 33 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 34 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 35 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 36 NORTH AMERICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
TABLE 37 NORTH AMERICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 92
TABLE 38 NORTH AMERICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 94
TABLE 39 NORTH AMERICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 94
TABLE 40 NORTH AMERICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 41 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 99
TABLE 42 NORTH AMERICA DIRECT TENDERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 43 NORTH AMERICA RETAIL SALES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 44 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 107
TABLE 45 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 46 NORTH AMERICA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 47 NORTH AMERICA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 48 NORTH AMERICA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 49 NORTH AMERICA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 50 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 109
TABLE 51 NORTH AMERICA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 52 NORTH AMERICA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 53 NORTH AMERICA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 54 NORTH AMERICA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 55 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 111
TABLE 56 NORTH AMERICA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 111
TABLE 57 NORTH AMERICA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 111
TABLE 58 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 112
TABLE 59 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 60 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 61 NORTH AMERICA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 62 NORTH AMERICA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 63 NORTH AMERICA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 113
TABLE 64 U.S. HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 65 U.S. INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 66 U.S. CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 67 U.S. HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 68 U.S. CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 69 U.S. HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 115
TABLE 70 U.S. PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 71 U.S. TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 72 U.S. TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 73 U.S. COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 74 U.S. HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
TABLE 75 U.S. OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 117
TABLE 76 U.S. 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 118
TABLE 77 U.S. HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 78 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 79 U.S. CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 80 U.S. LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 81 U.S. ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 82 U.S. HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 120
TABLE 83 CANADA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 84 CANADA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 85 CANADA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 86 CANADA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 87 CANADA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 88 CANADA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
TABLE 89 CANADA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 90 CANADA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 91 CANADA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 92 CANADA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 93 CANADA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 125
TABLE 94 CANADA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 125
TABLE 95 CANADA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 125
TABLE 96 CANADA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 126
TABLE 97 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 98 CANADA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 99 CANADA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 100 CANADA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 101 CANADA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
TABLE 102 MEXICO HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 103 MEXICO INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 104 MEXICO CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 105 MEXICO HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 106 MEXICO CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 107 MEXICO HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 130
TABLE 108 MEXICO PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 109 MEXICO TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 110 MEXICO TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 111 MEXICO COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 112 MEXICO HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 132
TABLE 113 MEXICO OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 132
TABLE 114 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 115 MEXICO CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 116 MEXICO LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 117 MEXICO ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 118 MEXICO HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 134

LIST OF FIGURES

FIGURE 1 NORTH AMERICA HIGH CONTENT SCREENING MARKET: SEGMENTATION 24
FIGURE 2 NORTH AMERICA HIGH CONTENT SCREENING MARKET: DATA TRIANGULATION 27
FIGURE 3 NORTH AMERICA HIGH CONTENT SCREENING MARKET: DROC ANALYSIS 28
FIGURE 4 NORTH AMERICA HIGH CONTENT SCREENING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 29
FIGURE 5 NORTH AMERICA HIGH CONTENT SCREENING MARKET: COMPANY RESEARCH ANALYSIS 29
FIGURE 6 NORTH AMERICA HIGH CONTENT SCREENING MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 NORTH AMERICA HIGH CONTENT SCREENING MARKET: DBMR MARKET POSITION GRID 32
FIGURE 8 NORTH AMERICA HIGH CONTENT SCREENING MARKET: MARKET APPLICATION COVERAGE GRID 33
FIGURE 9 NORTH AMERICA HIGH CONTENT SCREENING MARKET: VENDOR SHARE ANALYSIS 34
FIGURE 10 NORTH AMERICA HIGH CONTENT SCREENING MARKET: SEGMENTATION 37
FIGURE 11 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH-CONTENT SCREENING IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA HIGH CONTENT SCREENING MARKET IN THE FORECAST PERIOD 38
FIGURE 12 THE PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HIGH CONTENT SCREENING MARKET IN 2023 AND 2030 38
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA HIGH CONTENT SCREENING MARKET 44
FIGURE 14 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2022 53
FIGURE 15 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 54
FIGURE 16 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 54
FIGURE 17 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, LIFELINE CURVE 55
FIGURE 18 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2022 64
FIGURE 19 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 65
FIGURE 20 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, CAGR (2023-2030) 65
FIGURE 21 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY APPLICATION, LIFELINE CURVE 66
FIGURE 22 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2022 75
FIGURE 23 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 76
FIGURE 24 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, CAGR (2023-2030) 76
FIGURE 25 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE 77
FIGURE 26 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY END USER, 2022 86
FIGURE 27 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 87
FIGURE 28 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY END USER, CAGR (2023-2030) 87
FIGURE 29 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY END USER, LIFELINE CURVE 88
FIGURE 30 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2022 97
FIGURE 31 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 98
FIGURE 32 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 98
FIGURE 33 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 99
FIGURE 34 NORTH AMERICA HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 104
FIGURE 35 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 105
FIGURE 36 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 105
FIGURE 37 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 106
FIGURE 38 NORTH AMERICA HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 106
FIGURE 39 NORTH AMERICA HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 135